Suppr超能文献

庆大霉素和环孢素A对人体尿细胞磷脂及磷脂酶的形态学和生化作用

Morphological and biochemical effects of gentamicin and cyclosporin-A on urinary cell phospholipids and phospholipases in man.

作者信息

Chatterjee S, Bose S

机构信息

Department of Pediatrics, Johns Hopkins University, Baltimore, Maryland 21205.

出版信息

J Biochem Toxicol. 1988 Spring;3:47-57. doi: 10.1002/jbt.2570030106.

Abstract

The morphology, lipid composition, and activity of sphingomyelinase (E.C. 3.1.4.12) and phospholipases A (E.C. 3.1.1.32) and C (E.C. 3.1.4.3) were studied in the urinary cells from four normal subjects, four patients receiving gentamicin (G), and four patients receiving cyclosporin-A (CsA). We report that abnormal urinary excretion of proximal tubular cells occurred in patients receiving G and CsA. Membrane-enclosed sudanophilic material and numerous vacuoles were found in the cytoplasm of the proximal tubular cells from both patients receiving G and those receiving CsA. Patients receiving G shed higher levels of phosphatidylcholine (PC), phosphatidylethanolamine (PE), and sphingomyelin (SM) in the order of 78%, 38%, and 30% relative to normal. In contrast, the excretions of phosphatidylinositol (PI) and PC were 50% and 30% lower, respectively, in patients receiving CsA as compared to control. Sphingomyelin levels, however, were moderately elevated in these patients' urinary renal tubular cells. The activity of acid sphingomyelinase was one half the normal level in the cells of patients receiving G and CsA. The most striking result was a tenfold decrease in the activity of neutral sphingomyelinase in patients receiving G. In contrast, the activity of neutral sphingomyelinase in patients receiving CsA was similar to control. Phospholipase A activity was decreased and increased 35% and 15%, respectively, in urinary proximal tubular cells from patients receiving G and CsA. We conclude that deficient neutral sphingomyelinase activity precedes phospholipid (PL) overloading and gross pathological changes in patients receiving gentamicin but not in patients receiving cyclosporin-A.

摘要

对4名正常受试者、4名接受庆大霉素(G)治疗的患者和4名接受环孢素A(CsA)治疗的患者的尿细胞中鞘磷脂酶(E.C. 3.1.4.12)、磷脂酶A(E.C. 3.1.1.32)和磷脂酶C(E.C. 3.1.4.3)的形态、脂质组成及活性进行了研究。我们报告,接受G和CsA治疗的患者出现近端肾小管细胞异常尿排泄。在接受G治疗的患者和接受CsA治疗的患者的近端肾小管细胞胞质中均发现有膜包被的嗜苏丹物质和大量空泡。接受G治疗的患者排出的磷脂酰胆碱(PC)、磷脂酰乙醇胺(PE)和鞘磷脂(SM)水平相对于正常水平依次高出78%、38%和30%。相比之下,接受CsA治疗的患者与对照组相比,磷脂酰肌醇(PI)和PC的排泄量分别降低了50%和30%。然而,这些患者肾小管细胞中的鞘磷脂水平适度升高。接受G和CsA治疗的患者细胞中酸性鞘磷脂酶的活性为正常水平的一半。最显著的结果是接受G治疗的患者中性鞘磷脂酶的活性降低了10倍。相比之下,接受CsA治疗的患者中性鞘磷脂酶的活性与对照组相似。接受G和CsA治疗的患者尿近端肾小管细胞中磷脂酶A的活性分别降低和升高了35%和15%。我们得出结论,在接受庆大霉素治疗的患者中,中性鞘磷脂酶活性不足先于磷脂(PL)超载和严重病理变化,而在接受环孢素A治疗的患者中则不然。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验